Home » Topics » BioWorld Science

BioWorld Science
RSS

Glucocorticoid receptor agonist ADCs patented by AbbVie

Sep. 6, 2021

Lilly identifies new ketohexokinase inhibitors

Sep. 6, 2021

Discovery of novel potent pan-serotypic dengue antivirals

Sep. 6, 2021

Altered Chkb leads to cardiomyopathy, murine model shows

Sep. 6, 2021

Study elucidates how ApoE4 astrocytes influence neuronal amyloidosis

Sep. 6, 2021

New pyrimidinone amides as APJ receptor agonists identified for heart failure

Sep. 6, 2021

Mycobacterium tuberculosis inhibits the NLRP3 inflammasome through PknF to escape host immunity

Sep. 6, 2021

Aryl guanidine derivatives for invasive fungal infections found thanks to new mechanism of action

Sep. 6, 2021

SBIR grant supports Felix Biotechnology's work on engineering bacteriophage

Sep. 3, 2021

SymBio collaborates with NCCS to explore use of brincidofovir in EBV-positive lymphoma

Sep. 3, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...